Pages that link to "Q41090368"
Jump to navigation
Jump to search
The following pages link to Chronic changes in skeletal muscle histology and function in peripheral arterial disease (Q41090368):
Displaying 50 items.
- Exercise for intermittent claudication (Q24194839) (← links)
- Morphological, histochemical, and interstitial pressure changes in the tibialis anterior muscle before and after aortofemoral bypass in patients with peripheral arterial occlusive disease (Q24804446) (← links)
- Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease (Q28240884) (← links)
- A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF165b in peripheral arterial disease in human and mouse (Q30275400) (← links)
- Applications of In Vivo Functional Testing of the Rat Tibialis Anterior for Evaluating Tissue Engineered Skeletal Muscle Repair. (Q30275653) (← links)
- VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model (Q30432040) (← links)
- Exercise training and peripheral vascular disease (Q30866068) (← links)
- Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy (Q33349016) (← links)
- Resting energy expenditure in patients with intermittent claudication and critical limb ischemia (Q33869269) (← links)
- Peripheral artery disease: current insight into the disease and its diagnosis and management (Q33951581) (← links)
- Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective (Q34085963) (← links)
- Skeletal muscle BOLD MRI: from underlying physiological concepts to its usefulness in clinical conditions. (Q34270034) (← links)
- Haemodynamic limitations and exercise performance in peripheral arterial disease (Q34634274) (← links)
- Epidemiology and pathophysiology of peripheral arterial disease (Q34993502) (← links)
- Metabolic modulation and optimization of energy consumption in heart failure (Q35106491) (← links)
- Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function (Q35217900) (← links)
- Leg strength predicts mortality in men but not in women with peripheral arterial disease (Q35568944) (← links)
- Lower extremity nerve function, calf skeletal muscle characteristics, and functional performance in peripheral arterial disease (Q35569776) (← links)
- Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women with peripheral arterial disease (Q35635122) (← links)
- Taurine and skeletal muscle disorders (Q35678828) (← links)
- Abnormal myofiber morphology and limb dysfunction in claudication (Q35882665) (← links)
- Determinants of Slow Walking Speed in Ambulatory Patients Undergoing Maintenance Hemodialysis (Q35971385) (← links)
- Effect of limb demand ischemia on autophagy and morphology in mice. (Q36030804) (← links)
- Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: a longitudinal study (Q36301567) (← links)
- Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization. (Q36506159) (← links)
- Transforming growth factor-beta 1 produced by vascular smooth muscle cells predicts fibrosis in the gastrocnemius of patients with peripheral artery disease (Q36549555) (← links)
- Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease (Q36567518) (← links)
- Physical activity, walking exercise, and calf skeletal muscle characteristics in patients with peripheral arterial disease (Q36676706) (← links)
- Analysis of isokinetic muscle function and postural control in individuals with intermittent claudication (Q36808268) (← links)
- Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications. (Q36966063) (← links)
- Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease (Q37104307) (← links)
- Eccentric strength and endurance in patients with unilateral intermittent claudication (Q37222749) (← links)
- Walking performance is positively correlated to calf muscle fiber size in peripheral artery disease subjects, but fibers show aberrant mitophagy: an observational study (Q37299323) (← links)
- Oxidative damage and myofiber degeneration in the gastrocnemius of patients with peripheral arterial disease (Q37361610) (← links)
- Resting energy expenditure in subjects with and without intermittent claudication (Q37380999) (← links)
- Propionyl l-carnitine: intermittent claudication and peripheral arterial disease (Q37614555) (← links)
- Mitochondrial Bioenergetics in the Metabolic Myopathy Accompanying Peripheral Artery Disease (Q37694486) (← links)
- Rehabilitation in patients with peripheral arterial disease (Q37932162) (← links)
- Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI. (Q37989063) (← links)
- Intermittent claudication: new targets for drug development (Q38115205) (← links)
- Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease (Q38421171) (← links)
- Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice (Q38799483) (← links)
- Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. (Q39674949) (← links)
- Low ankle-brachial index is a predictive factor for initial severity of acute ischaemic stroke (Q40018612) (← links)
- Does lower-extremity arterial disease predict future falling among older men and women? (Q40145470) (← links)
- Exercise intolerance in patients with chronic heart failure. (Q40457694) (← links)
- The propionyl-l-carnitine hypothesis: An alternative approach to treating heart failure (Q41611759) (← links)
- Skeletal muscle metabolism as a target for drug therapy in peripheral arterial disease (Q41740351) (← links)
- Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain (Q41904181) (← links)
- Calf muscle perfusion as measured with magnetic resonance imaging to assess peripheral arterial disease. (Q42856665) (← links)